Several therapies have been developed for congenital nystagmus (CN) but without placebo-controlled trials. We investigated a treatment which combined two therapies that had been advocated by several authors and were reported to improve visual acuity (VA). A placebo treatment was designed to mimic the time, attention, 'high tech' apparatus, and the explanation used in the experimental treatment. To each group, 38 subjects with CN were randomly allocated. Their VA and contrast sensitivity (CS) were assessed three times before undergoing treatment for 6 weeks and then once more. An improvement in VA occurred, however, this was not significantly different in the two groups. The improvement in CS was greater in the experimental than in the control group, but the difference failed to reach significance in most statistical tests. We conclude that putative therapies for CN should be assumed to be placebos until proven otherwise with randomized controlled trials.
Introduction
Congenital nystagmus (CN) describes all forms of nystagmus which are present within the first four months of life [1] . There are three sub-types of congenital, or early-onset, nystagmus [2] . In sensory defect nystagmus, CN is associated with a sensory defect in the visual pathway [2, 3] . Albinism is a relatively common cause of this sensory defect [1, 2, 4] . A second type of CN is neurological nystagmus, resulting from a neurological disease [2] . This is rare, is not included in most classifications [1] , and will not be discussed in the present paper. The third type of CN occurs in the absence of known pathological causes and is called congenital idiopathic nystagmus, or motor nystagmus [2] . The diagnosis of idiopathic CN is by exclusion, and therefore depends on the depth of investigation.
CN causes difficulties for two reasons: (1) reduced visual acuity (VA); and (2) cosmetic disadvantage. It is the reduction in VA which causes sufferers greatest problems, and an improvement in VA is their main aim when seeking treatment [5] . The poor VA imposes restrictions on people's lifestyles and few people with nystagmus are legally permitted to drive in the UK [2] .
Usually, the VA is between 6/12 and 6/36 and improves with age [6] , but almost invariably remains below normal. CN is often associated with hypermetropic astigmatism [7] . Approximately one third of patients have a null zone in eccentric gaze, and many adopt a compensatory head posture [6] . Approximately 8% have a null zone on convergence [1] and there may also be a temporal null zone [1] .
Causes of poor 6ision in congenital nystagmus
Whatever the underlying aetiology of the nystagmus, some of the reduced VA is likely to be attributable to the constant oscillation of the eyes, with reduced foveation period 1 [9] . Any treatment directed at this motor element should not just be aimed at reducing the nystagmus, but also at changing the waveform to one 1 The foveation period occurs when the target of regard is imaged at or near the fovea and is characteristically associated with a slowing of eye velocity [8] .
with a longer percentage foveation time per cycle [1, 10] . Since CN occurs during the sensitive period, the reduced VA resulting from the eye movements will cause meridional amblyopia [10] , which may be compounded by meridional amblyopia from astigmatism [11] . As the child ages, the amplitude of nystagmus usually reduces [2] , so that the reduced vision in older children and adults may be attributable in part to the ocular oscillation and in part to amblyopia [13, 14] reviewed by [5] . Spierer [15] even believed that, in children outside the sensitive period, this amblyopia was the major reason for poor vision in CN. It therefore seems conceivable that people with CN might benefit from amblyopia treatment as well as interventions aimed at remediating the ocular oscillations.
Attempts to treat congenital nystagmus
Careful refraction and appropriate correction is important [2, 16] . Contact lenses often bring about a small additional improvement in visual performance [17] , probably due to enhanced feedback through the lid sensation [18] . Surgical techniques can be successful [19] , however, they are only appropriate in some cases [6] . One surgical procedure allows the patient to fixate in their null position without adopting an anomalous head posture [2] . A similar approach can be taken, for eccentric null zones, with yoked prisms and, for convergent null zones, with base out prisms or negative lenses [20, 21] .
Auditory biofeedback [21 -26] and visual biofeedback [27] have been used to treat CN, however, there have been no randomized double-masked placebo-controlled trials (RCTs).
When presented with an after-image, most people with CN report that the after-image oscillates. This oscillation is in time with the nystagmus [28] , but of lesser amplitude [29] . This 'after-image feedback' (AIF) has been used in treatment regimens, first by Goldmann (cited by Stohler [30] ) and subsequently by others [21, 30, 31] , but there have been no RCTs.
There have been a few attempts to treat nystagmus with therapies designed to treat amblyopia [32, 33] , but no RCTs. Mallett developed an instrument for active [55] amblyopia therapy [33] which he also found to be effective for treating CN [16] . This instrument uses intermittent photic stimulation (IPS) whilst the patient carries out detailed visual tasks using specially designed targets. The targets are dots, stripes, numbers, and letters on transparent plates which are back-illuminated with a red light flashing at 4 Hz [33] . IPS therapy for CN has been recommended by some authors [34, 35] and has been used in open trials and case studies [16, 21, 35] .
More recently, the Mallett treatment regimen was modified to include visual feedback by creating a parafoveal after-image. Patients attempt to reduce the oscillation of the after-image whilst viewing the IPS unit. The treatment usually takes place at weekly sessions of 40 min and continues until there have been no further improvement in VA for six weeks. An unpublished open trial suggested that the combined IPS and AIF treatment was an improvement on the original IPS treatment [36] .
Although the results of the case studies and open trials described above have been encouraging, these studies have not been controlled for several potential confounding variables, i.e. placebo, Hawthorne, and chart-learning/practice effects. RCTs are especially important in CN because the nystagmus and VA often worsen when patients are under stress [2] or when they are trying to see more clearly [16] . Hence, on subsequent visual assessments, patients might be expected to improve simply through becoming more relaxed about having their vision assessed.
The aim of the present study was to carry out an RCT of the use of IPS and AIF to treat CN. Specifically, we sought to investigate the claims of Mallett [16] who treated patients aged seven and over with CN. Like Mallett [36] , we included patients with sensory defect nystagmus resulting from albinism. Mallett [16] found that ''the major beneficial effect has been to improve the visual acuity'', and this was the key variable investigated. We believe that this is the first RCT of a therapy for CN.
Methods

Subjects
Subjects (Ss) were found through publicity by the Nystagmus Network, a charitable organisation. The publicity, explanatory literature, and descriptions to patients stated that the purpose of the study was to compare two putative therapies for CN. All Ss who met the following selection criteria were entered in the study: 1. No personal history of epilepsy (to avoid the slight risk of IPS inducing a fit [33] . 2. No knowledge of IPS that would allow them to differentiate the control from the active therapy. 3. Early onset nystagmus [2] . Many Ss were vague about the age of onset and these Ss were only included if there was an ophthalmological diagnosis of CN. 4. The nystagmus must, at some time, have been medically investigated and a pathological cause (other than oculocutaneous or ocular albinism) excluded. We wrote to the diagnosing ophthalmologists and asked them to confirm the diagnosis.
5. The minimum age was set at 8 years to ensure that all Ss understood the instructions and were able to attend to the treatments. Ss, or a parent or guardian, had to sign an informed consent form (the study was approved by the Institute of Optometry Research and Ethical Committee). 6. Ss were required to have had a recent (within the last year) eye examination at the Institute of Optometry and had to be wearing any appropriate refractive correction. Ss were randomly allocated to a group receiving the experimental treatment and a group receiving the control treatment. After the first three Ss in each group had completed the study their results were used in a statistical power calculation to calculate the number of Ss required to reject the null hypothesis, if the experimental therapy was effective 2 [37] .This gave a target number of 18 in each group and the final number of Ss was 19 in each group. The mean age of the sample was 24 years and the inter-quartile range was 14 -27 years. The mean ages of the two groups were not significantly different (t-test, P \ 0.05).
Clinical assessments
Ss received a detailed eye examination prior to entry to the study, including biomicroscopy to detect iris transillumination. If necessary, refractive corrections were updated.
Research 6isual assessments
The data that were used to assess the efficacy of the treatments were obtained using a battery of tests (research visual assessments) which were administered four times, three times before treatment and once after treatment. Repeating the pre-treatment measures established intra-subject variability and identified any practice effects.
The research visual assessments concentrated on the detailed measurement of VAs, and contrast sensitivity (CS). We chose to concentrate on assessing any improvement in VA since this was our Ss' main goal and the relationship between VA and eye movement parameters in CN may be not be very predictable [12] . We recognised that if we did demonstrate a significant improvement in VA that future research would be needed to study eye movements. If the treatment did not improve VA, then an investigation into its effect on eye movements would be unwarranted.
All VA and CS measures were carried out with the patient's usual refractive correction, and under binocular conditions. The research visual assessments were carried out by optometrists (authors: Bruce J.W. Evans, Janyce Jordahl-Moroz, Mustafa Nabee) who were unaware of which treatment Ss had received (Ss were asked to help maintain this 'mask'). For all Ss, high contrast VA was measured first, followed by low contrast VA, then CS.
High and low contrast 6isual acuity (VA)
Bailey-Lovie LogMAR charts [38] were used at a distance of 4.8 m. The logarithmic progression meant that the viewing distance could be altered to 1.5 m in cases of very poor VA. The minimum testing distance was 1.5 m to avoid any significant effect from convergent null zones [39] . Both high contrast charts were placed side by side so that there were 10 letters on each line.
A 26 alternative 3 forced choice one-up-one-down staircase procedure [45] was used. The S was directed to the first letter (on the left) on the top line (largest size) and asked to name the letter or forced to guess. If incorrect, then the testing distance was changed to 1.5 m. If correct, then the S was directed to the first letter on the second line, and so on. When the S made an error, the examiner moved one step (line) up, to the next larger size of letter, asking the S to read the first letter they had not already attempted to read on that line (in this example, the second letter). This procedure was repeated, with the S always moving up a line when wrong and down a line when correct, and always attempting the first unread letter on the relevant line. The results were graphed as the testing progressed until all 10 letters on any one line has been attempted once. The graph revealed 'reversals', which can be characterised as peaks and troughs. The first reversal was ignored and the threshold was determined from the mean of all the other peaks and troughs, except for the last when there was an odd number of peaks and troughs [40] .
This type of 'staircase method' requires the presentation of fewer stimuli than other methods and is practically as efficient as maximum likelihood procedures [41] . Compared with more conventional methods [42] , our method meant that Ss were unlikely to learn the charts (the two adjacent charts were regularly interchanged) and wasted less time reading letters that they found to be very easy or impossible, but read all the letters of a size closest to threshold. The method also had an adaptive element in that more variable Ss would have read more letters.
The optometrist identified which letter Ss should attempt by pointing to the side of the line and asking the patient to read the appropriate letter (e.g. 'second letter'). This pointing should have had little effect on any localization problems resulting from the primarily horizontal nystagmus.
An identical procedure was used with the BaileyLovie low contrast (10%) charts.
Contrast Sensiti6ity (CS)
Bradley et al. [43] showed that the optimal way to describe visual function may be to measure high and low contrast VA and to assess the CS at 4 cycles per degree (cpd). Therefore, Cambridge Low Contrast Gratings [44] were used to measure CS at 4 cpd. This test uses a 2-alternative forced-choice one up four down algorithm [44, 45] . The CS was tested first with the gratings horizontal and then vertical [11, 23, 46] .
Questionnaires
To obtain background information and to investigate Ss' perceptions of any benefit from treatment, we asked them to complete pre-and post-treatment questionnaires. These are paraphrased in Tables 1 and 2 and they used, where appropriate, continuous performance scales.
Procedure for the experimental treatment
Both the experimental and the control treatment were administered by a trained research assistant (author: Bettine V Evans) who was unaware that one of Table 2 Post-treatment questionnaire (paraphrased)
1.
When viewing objects since you have had the treatment, have you ever noticed that anything appears to be wobbling or moving? 2.
If yes how often do you notice objects wobbling or moving? 3.
Compared with before the treatment, how bothersome is any wobbling or movement that you now experience? 4.
What effect has the treatment had on your ability to resolve fine detail? 5.
If improved, for how long after each treatment session and at distance or near? What effect has the treatment had on your general ability 6.
to see things in everyday life? 7.
If improved, for how long after each treatment session? 8.
What effect has the treatment had on any tendency to turn your head with your nystagmus? 9.
If improved, for how long after each treatment session? 10. What effect has the treatment had on your general selfconfidence and ability to live a full life? 11. If improved, for how long after each treatment session?
If only one of the two treatments that we have been inves-12.
tigating turns out to be effective, do you think that it will be the one that you have been receiving? 13. Do you feel that it would have helped you to continue with the treatment for longer? 14. If so, how long?
Please list any improvements in the treatment that you have 15.
received that you wish to suggest.
the treatments was designed to be an ineffective control. She was provided with the same explanation as that given to the Ss (see below). The treatments were administered in different rooms, so that Ss did not see the alternative treatment. As recommended by Mallett [33] , both treatments were carried out binocularly, unless the patient was monocular (strabismic) when they were carried out monocularly. The procedure for the experimental treatment was the same as that used for the treatment of CN in the Institute of Optometry clinics, as developed by R.F.J. Mallett. The only difference for the present research was that the measurement of VAs, which in the clinic preceded each treatment session, was omitted.
The IPS unit which was described in detail by Mallett [33] was used in the present study, and Ss were familiarised with this. They subsequently fixed the centre of an opaque disc (diameter 1.8 cm) placed centrally in the screen (5×3 cm) of a flash gun, into which had been inserted a UV-blocking filter. The flash gun was held 50 cm from the S and a flash was triggered.
With the room lights dimmed, the S viewed a grey wall and was asked to observe the after-image. All Ss reported seeing the after-image oscillating and it was explained that this corresponded to their ocular oscillations. The S was then directed to an item of detail (e.g. a dot, letter or number) on the perspex stimulus plate of an IPS unit [33] . They were asked to try to minimise the movement of the after-image whilst trying to make the detail as clear as possible. Their attention was then directed to another item of detail and they were instructed as above. This was repeated for 5 min, when the plate was changed for one with smaller detail. Throughout the treatment session, the plates were made progressively more detailed until the patient could only just resolve the detail. The flash was replenished every 5 min. The procedure was continued for 6 flashes, or 30-40 min (monocular subjects were treated for 25 min each eye). The following explanation was given to Ss: the purpose of the after-image was to help them learn to reduce their eye movements; the detail on the IPS unit was designed to stimulate different types of nerve fibre running from the eye to the brain; the red background on the IPS unit was designed to help them fixate centrally; and the flashing of the IPS was designed to stimulate the eye's fixation reflex.
Procedure for the control treatment
The control therapy was designed to mimic the attention, equipment, and time involved in the experimental therapy. A full-field (Ganzfeld) after-image was created and Ss were directed to trace or colour targets over a rotating grating on a CAM stimulator. The CAM stimulator is a therapy that was once advocated for amblyopia [47] , but was later shown to be a placebo [48, 49] . In the amblyopia treatment, patients traced on transparent perspex plates which were placed over rotating square wave gratings. The theory was that the gratings would stimulate cells in the visual cortex. To ensure that this type of therapeutic effect did not inadvertently take place in the present study, the square-wave gratings were replaced with a 0.5 cpd sine wave grating. People with CN actually have enhanced contrast sensitivities to spatial frequencies below 1 cpd [1] , and such spatial frequencies are unrelated to VA. The details of the procedure are as follows.
The S was familiarised with the CAM unit. The same flash gun was used as for the experimental treatment. The Ss chin was placed on the chin rest of a Zeiss bowl perimeter in a darkened room. The perimeter was modified so that a circular piece of white card was placed over the central fixation area. Effectively, the S's whole field of view was a uniform white field. The flash gun was held between the top of the S's head and the top of the bowl, facing towards the bowl but behind the S's forehead. The flash was triggered.
The S was asked to appreciate the unusual after-image (the effect of this full field, or Ganzfeld, after-image is peculiar: a large bright area that rapidly disappears). When they reported that their vision had returned to normal, their attention was directed to the CAM stimulator and they were instructed to trace or colour in shapes on the perspex plate. Ss were repeatedly encouraged and, after 5 min, the plate was changed for a different one, as with the IPS unit. The Ganzfeld afterimage was repeated every 5 min, approximately. The duration of each treatment session was similar to that for the experimental treatment.
The following explanation was given to Ss: the purpose of the after-image was to ''wipe the visual slate clean'' by ''clearing away all previous images''; the rotating grating on the CAM unit stimulated the different types of nerve fibre running from the eye to the brain; and the tracing and colouring improved handeye co-ordination and improved eye movement control. The CAM stimulator is a similar size and shape to the IPS unit. It was felt that the rotating grating, with appropriate explanation, was as likely to be associated with a placebo effect as the flashing red light on the IPS unit. Ss in both groups appeared to be satisfied by the explanations. for the horizontal orientation CS all passed the test of normality (P\ 0.18) with the exception of the final assessment (P= 0.04). All of the distributions for the vertical CS passed the test of normality (P\ 0.35). Therefore, parametric statistics were used, however, the principal findings were checked and additional analyses were carried out with non-parametric tests.
Within each group, Meddis' [50] program of ANOVA by ranks was used, with Sheffes method of post-hoc comparison for order effects, to investigate whether the first three measurements of each variable showed a significant order effect. They did not (P\ 0.05), justifying calculating mean pre-treatment values.
Three different statistical approaches were taken, each of which provided some unique information. First, for each variable the difference between the mean pretreatment value and the post-treatment measure was calculated. These were not significantly different in the two groups, for any of the variables (t-test, P\ 0.20). For each S, based on the mean and S.D. of his/her three pre-treatment measures, the z-scores of improvement in each variable were calculated. The mean z-scores of the two groups were not significantly different (t-test, P\ 0.5) except for the Cambridge gratings vertical orientation where the experimental group improved by more than the CAM group (t-test, P= 0.043). The number of subjects in each group who improved by two or more standard deviations was calculated (using their own, individual, standard deviations). This did not differ significantly in the two groups (Chi-square, P\ 0.40), except for the vertical CS where significantly (Chisquare, P=0.0013) more members of the experimental group improved by two or more standard deviations.
For the second analysis, a repeated measures ANOVA was used to compare the mean pre-treatment measures with the post-treatment results. The S group was the between-subjects factor (independent variable), and the effect of treatment on the dependent variable (VA or CS) was the within-subjects factor. The BaileyLovie high contrast VA was, for all subjects together, significantly better after the treatment than before (F(1, 36) =13.70, P=0.001). However, there was no significant effect of group (F(1, 36)= 2.43, P= 0.13), nor a significant interaction of (group x treatment) (F(1, 36)=0.02, P= 0.90). This suggests that the improvement in high contrast VA was not significantly greater in the IPS group, and seems most likely to be practice/placebo effects. A similar ANOVA for low contrast VA showed no significant effect of group (F(1, 36)=1.76, P=0.19), treatment (F(1, 36) = 0.73, P= 0.40), or interaction of (group x treatment) (F(1, 36)= 0. 0.06, P=0.81). For the horizontal orientation CS, there was a just significant effect of group (F(1, 36)= 4.13, P=0.05), but no significant effect of treatment (F(1, 36) =2.90, p=0.097), nor interaction of (group x treatment) (F(1, 36)= 0.65, P= 0.43). For the vertical orientation, there was no significant effect
Results
Research 6isual assessment data
The results are illustrated in Figs. 1 -4 . An improvement is represented by decreasing LogMAR and increasing CS. Although Figs. 1 -4 show that, by chance, the experimental group had slightly better visual performance than the control group; this difference was not statistically significant for the mean pre-treatment value for any of the variables (unpaired t-test, P\ 0.10).
To check whether these data were normally distributed, frequency distributions were inspected and the Kolmogorov-Smirnov test was used to compare these with normal distributions. High and low contrast VA were clearly normally distributed (P \0.35). The data of group, treatment, nor interaction of (group x treatment) (F(1, 36)B2.31, P \ 0.13) .
For the third analysis, a non-parametric analysis of variance by ranks [50] was used, for each group and each variable, to determine whether there was a significant difference between any of the ranked means of the four repeated measures. None reached significance at the P = 0.05 level. Sheffes method of post-hoc comparison was then used to test individual hypotheses for order effects. The particular hypotheses that were tested were that (a) the last reading was significantly different (with VA lower and CS higher) to the first three; (b) each reading was successively lower/higher (lower for VA, higher for CS) than the last; (c) the first reading was significantly lower/higher (higher for VA, lower for CS) than the others. Only two order effects approached significance. In the experimental treatment group and for the horizontal orientation CS the final reading was significantly better than the first three (P= 0.044), however, this was likely to be partly due to an order effect since each reading tended to be successively better than the previous one (P=0.55). In view of the large number of statistical tests which were carried out to investigate these order effects, we feel that these marginal effects are unlikely to be meaningful.
Indi6idual trends
To determine if there were any particular features of the Ss whose VA improved most, the following variables were inspected: age, diagnosis (CN with or without albinism); certainty of diagnosis (based on information from ophthalmologist); family history; eye movement characteristics; refractive error; strabismus; stereopsis; and amblyopia. The eye movement characteristics were obtained, for all subjects, by clinical gradings of the type of movement (pendular or jerk), direction of eye movements (horizontal, vertical, circumrotatory), and magnitude of eye movements (clinically graded as [1] [2] [3] [4] [5] . Independent analysis of eye movement recordings were obtained for six Ss. No significant differences between the two groups were apparent for any of these variables (P \ 0.05).
Questionnaire data
A similar proportion of each group (four from experimental and three from the control group) had a diagnosis of albinism and six of the experimental and three of the control group had an immediate family member with nystagmus. None of the Ss had received any previous nystagmus treatment, other than refractive correction.
The data from the final questionnaire showed that the two groups did not differ significantly (P \0.05) in any of the variables numbered 2 -14 in Table 2 . On average, the duration of any perceived improvements was described as lasting for more than 3-4 days but less than all week; but these reports did not differ significantly in the two groups. It is interesting to note that subjects in both groups reported a mean improvement in their ability to resolve fine detail of 15% compared with a mean improvement in high contrast VA, from first to final assessment, of 7%.
Discussion
The claims that we were investigating related to a heterogeneous group of patients with CN and our sample reflected this heterogeneity. Indeed, most research studies on putative therapies for CN have not set selection criteria based on whether the aetiology is idiopathic, albinotic, or other sensory defect [16, 21, 23, 25, 51] .
VA improved a small amount with practice, and more following interventions that were described as therapeutic, gave Ss individual attention, and involved 'high tech' equipment ( Figs. 1 and 2 ). The improvement in VA that was associated with the experimental treatment was not significantly different to that associated with the control treatment.
The findings with CS were less clear-cut. The z-score analysis suggested that vertical CS increased more in the experimental group. The non-parametric ANOVA did not reveal any significant order effect for the vertical orientation, however, it did detect a barely significant order effect for the horizontal orientation. The parametric ANOVA did not reveal any significant interactions of group x treatment.
We attempted, for the experimental group, to correlate the z-score of improvement for each of the four variables with any perceived improvement in the ability to resolve fine detail and to see in everyday life. Neither of these questionnaire variables correlated significantly with any of the z-scores (r s B 0.50, P\ 0.08).
Although the border-line CS findings may be interesting and could be investigated further, the main reason why people in the UK with CN seek treatment is to pass their driving test [16] . This is dependent on high contrast VA and the present study suggests that the improvement in this variable with treatment is most likely to be attributable to practice and placebo effects.
Were six treatment sessions enough?
It is possible that we failed to detect a treatment-specific improvement in the experimental group as the number of treatment sessions was too few. To investigate this, we studied the records of 25 patients who had attended the Institute of Optometry clinics for IPS treatment (with or without after-image feedback) for a prolonged period. Most of these clinical cases, who were selected randomly, were treated in the 1980s under the supervision of Mr Mallett. The VAs (Snellen chart or E-chart) that had been recorded before each treatment session were converted to LogMAR values. The data for the right eye were used, unless the patient was strabismic when the better eye was used. Graphs were plotted of VAs v. treatment session number for all 25 patients who were treated for 13 sessions and for the 13 of these patients who were treated for 30 sessions (Fig. 5) . Fig. 5 shows a very marked improvement after the first treatment, a fairly rapid improvement over the first five sessions, a slower improvement up to approximately the 12th treatment, and then a plateau. These findings support the hypothesis of practice/placebo effects, which were initially marked and then reduced as they approached the physiological limit of VA. Since the most rapid improvement occurred over the period which was investigated in the double-masked trial it seems likely that there would have been a divergence of the data for the experimental and control groups if there had been a genuine treatment effect.
The improvement in VA in the clinical data (Fig. 5 ) is similar to that reported in the clinical data from Mallett [16] and is much greater than that in the present study (Fig. 1) . This is not surprising, since the standard clinical method of having patients read an identical chart, letter by letter, before each treatment session would have enhanced practice and placebo effects. In contrast, our research protocol and psychophysical method were designed to minimize and control these effects. In addition, the clinical VA charts lacked the design features of the Bailey-Lovie charts [38] and viewing distance and testing protocol may not have been as strictly enforced in the clinic as in the research.
Validity of dependent 6ariables
We sought to investigate Mallett's [16] claim that ''the major beneficial effect has been to improve the visual acuity''. An improvement in high contrast VA is also the main goal of patients seeking treatment. A detailed analysis of eye movement characteristics is important to investigate the aetiology of an improvement, however, we felt this would be premature.
An interesting alternative approach was taken by Sheth et al. [51] who investigated a different putative therapy for CN. They analysed the eye movement parameters which most influenced VA and determined an 'acuity function' that, in their small sample, correlated well (r 2 = 0.90) with VA. They then analysed the effect treatment had on this function. This approach was important in their study, which investigated the instantaneous effect of a treatment. In our study, we wanted to know the effect of treatment in everyday life and our psychophysical method of measuring VA involved repeated measures which would average out moment-to-moment variations in the nystagmus. Sheth et al. [51] do not describe their sample, which may have been selected to have more homogeneous eye movement characteristics than ours. In any event, since our aim was to determine whether the treatment affected VA, even if we had adopted the Sheth et al. approach and could match their r 2 of 90%, this would have reduced the power of our study to detect change by 10%.
Other treatments: the need for RCTs
Most nystagmus treatments possess characteristics known to exaggerate a placebo effect [51] and the relationship between psychological variables, such as stress, and nystagmus further increases the importance of controlling for the placebo effect.
If the present study had not been placebo-controlled and had only compared the experimental group's first high contrast VA result with their last, then the study would have reported a statistically significant improvement (paired t-test, P= 0.04). However, Fig. 1 shows that this improvement was mirrored in the control group. Hence, without the elements of the present study designed to assess practice and placebo effects, this research would have reached a completely inappropriate conclusion.
Leung et al. [21] , in their open trial of multifaceted vision therapy for CN, argued that a placebo effect seemed unlikely as all of their patients had received previous therapy. This view is not supported by the literature on the placebo effect [52 -54] .
Conclusions
The data suggest that, although IPS and AIF bring about an improvement in VA in patients with CN, this improvement is most likely to be attributable to practice and placebo effects. Whilst we cannot rule out the possibility that other measures of visual function might show an improvement, or that a sub-group of patients might respond better, this seems unlikely from the present data. We recommend that putative treatments for CN should be assumed to be placebos until proved otherwise with RCTs.
